Aim of the webinar:
- To discuss the controversy regarding managing potential donors with high hemoglobin
- To describe the prevalence of the JAK2 V617F mutation among blood donors and understand its significance
Level of education required:
1 - Fundamental Awareness (basic knowledge)
What knowledge is required?
We'd recommend you to read the below publications before the webinar
- Alsharif MH, Mansory EM, Alharazi AA, Badawi MA. JAK2-V617F mutation among blood donors: A meta-analysis. Saudi Med J. 2024 Dec;45(12):1289-1304. doi: 10.15537/smj.2024.45.12.20240594. PMID: 39658117; PMCID: PMC11629640.
Target audience
Scientists, blood bankers, master of PhD students, experts in blood donor eligibility, and hematologists
The Speakers
Maha Badawi
Nour Al-Mozain
Nour is Haematopatgology and Transfusion Medicine Physician at King Faisal Specialist Hospital & Research Center. Her passion for transfusion medicine started by realizing the profound interaction between basic science, laboratory medicine, and clinical practice.
It is an opportunity to learn a new thing every day. You are not only required to identify what went right and what went wrong. However, you will constantly be stimulated to determine further what could be done better and forecast a better practice for the future. Adding to all of that, the are not many doctors around the world who are encouraged to have this as a specialty, so she decided to have it as her career to provide patient care uniquely and differently. Besides, she is a big advocate for this specialty among the younger generation.
